Before you sell to, join or invest in Galera Therapeutics, Inc.
MentionFox check on Galera Therapeutics, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/galera-therapeutics-inc-form-d-25000002
Check Galera Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Galera Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-01-13.
Galera Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 13, 2025. The filing reports $2.74M sold. Its industry group is Pharmaceuticals. It names J. Sorensen (Executive Officer, Director), Joel Sussman (Executive Officer), Lawrence Alleva (Director) (SEC Form D, January 13, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Galera Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-01-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Galera Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Galera Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when Galera Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Galera Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Galera Therapeutics, Inc. →Get the full cited report on Galera Therapeutics, Inc.
What the filing shows about Galera Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Galera Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Galera Therapeutics, Inc.'s address as 45 Liberty Boulevard, Suite 230, Malvern, PA 19355.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Galera Therapeutics, Inc. See pricing
Galera Therapeutics, Inc. is a registered filer with the SEC (CIK 1563577) and has filed since 2025-01-13. 2 filings are on record, the latest on 2025-01-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Galera Therapeutics, Inc.'s Form D of 2025-01-13 names J. Sorensen, Joel Sussman, Lawrence Alleva and 3 more as its officers, directors or promoters.
Its new offerings report $5.62M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
J. Sorensen is named as Executive Officer and Director on the Form D that Galera Therapeutics, Inc. filed with the SEC on 13 January 2025, one of 6 people that filing names.
Joel Sussman is named as Executive Officer on the Form D that Galera Therapeutics, Inc. filed with the SEC on 13 January 2025, one of 6 people that filing names.
Lawrence Alleva is named as Director on the Form D that Galera Therapeutics, Inc. filed with the SEC on 13 January 2025, one of 6 people that filing names.
Nancy Chang is named as Director on the Form D that Galera Therapeutics, Inc. filed with the SEC on 13 January 2025, one of 6 people that filing names.
Michael Friedman is named as Director on the Form D that Galera Therapeutics, Inc. filed with the SEC on 13 January 2025, one of 6 people that filing names.
Kevin Lokay is named as Director on the Form D that Galera Therapeutics, Inc. filed with the SEC on 13 January 2025, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2025-01-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Galera Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Galera Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Galera Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Galera Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Galera Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Galera Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Philadelphia
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/galera-therapeutics-inc-form-d-25000002